Prognostic value of serum CYFRA21-1 and CEA for non-small-cell lung cancer

The aim of the study was to assess the clinical prognostic value of serum cytokeratin 19 fragment (CYFRA21-1) and carcinoembryonic antigen (CEA) for non-small-cell lung cancer (NSCLC) patients. Literatures related to effects of serum CYFRA21-1 and CEA on the prognosis of lung cancer patients were re...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhi-Hui, Han, Yun-Wei, Liang, Hui, Wang, Le-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673989/
https://www.ncbi.nlm.nih.gov/pubmed/26333429
http://dx.doi.org/10.1002/cam4.493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673989/
https://www.ncbi.nlm.nih.gov/pubmed/26333429
http://dx.doi.org/10.1002/cam4.493

Ejemplares similares